Similar articles

• Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.

  Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B. Kieler H, et al. BMJ. 2012 Jan 12;344:d8012. doi: 10.1136/bmj.d8012. BMJ. 2012. PMID: 22240235
• Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.

  Wooltorton E. Wooltorton E. CMAJ. 2006 May 23;174(11):1555-6. doi: 10.1503/cmaj.060509. Epub 2006 May 2. CMAJ. 2006. PMID: 16670395 Free PMC article. No abstract available.
• [Medical treatment of depression during pregnancy or breast feeding].

  Terp IM. Terp IM. Ugeskr Laeger. 2007 Jun 4;169(23):2233; author reply 2233, 2235. Ugeskr Laeger. 2007. PMID: 17607851 Danish. No abstract available.
• Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.

  Fenger-Grøn J, Thomsen M, Andersen KS, Nielsen RG. Fenger-Grøn J, et al. Dan Med Bull. 2011 Sep;58(9):A4303. Dan Med Bull. 2011. PMID: 21893008 Review.
• [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

  Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC. Favrelière S, et al. Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Encephale. 2010. PMID: 20513456 Review. French.